After a few years hanging out quietly on the sidelines, the Health Care sector roared back to prominence this year as COVID-19 ravaged the globe. Suddenly, vaccines and antibodies catapulted into the headlines, drawing attention to biotech and pharma amid a race to treat or prevent the virus.
While Health Care doesn’t lead the sector scoreboard this year, it’s holding its own. On one particular week in late June, four of the top-performing S&P 500 stocks were pharmaceutical or biotech companies.
The pandemic also upended the sector in other ways, with possible long-term impacts on everything from future merger and